genOway Société anonyme (EPA:ALGEN)

genOway Société anonyme Statistics

Total Valuation

EPA:ALGEN has a market cap or net worth of EUR 22.87 million. The enterprise value is 35.23 million.

Market Cap	22.87M
Enterprise Value	35.23M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:ALGEN has 9.22 million shares outstanding.

Current Share Class	9.22M
Shares Outstanding	9.22M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 17.77.

PE Ratio	17.77
Forward PE	n/a
PS Ratio	0.84
PB Ratio	1.24
P/TBV Ratio	1.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	27.37
EV / Sales	1.30
EV / EBITDA	10.01
EV / EBIT	45.92
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.79.

Current Ratio	2.50
Quick Ratio	2.26
Debt / Equity	0.79
Debt / EBITDA	4.12
Debt / FCF	n/a
Interest Coverage	3.85

Financial Efficiency

Return on equity (ROE) is 7.11% and return on invested capital (ROIC) is 1.68%.

Return on Equity (ROE)	7.11%
Return on Assets (ROA)	1.36%
Return on Invested Capital (ROIC)	1.68%
Return on Capital Employed (ROCE)	2.40%
Revenue Per Employee	183,526
Profits Per Employee	8,695
Employee Count	141
Asset Turnover	0.77
Inventory Turnover	10.23

Taxes

Income Tax	-26,123
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.49% in the last 52 weeks. The beta is 0.55, so EPA:ALGEN's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-27.49%
50-Day Moving Average	2.83
200-Day Moving Average	3.11
Relative Strength Index (RSI)	23.71
Average Volume (20 Days)	4,262

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:ALGEN had revenue of EUR 27.16 million and earned 1.29 million in profits.

Revenue	27.16M
Gross Profit	14.76M
Operating Income	767,106
Pretax Income	1.26M
Net Income	1.29M
EBITDA	3.52M
EBIT	767,106
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 2.13 million in cash and 14.49 million in debt, giving a net cash position of -12.36 million or -1.34 per share.

Cash & Cash Equivalents	2.13M
Total Debt	14.49M
Net Cash	-12.36M
Net Cash Per Share	-1.34
Equity (Book Value)	18.39M
Book Value Per Share	n/a
Working Capital	10.27M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 54.33%, with operating and profit margins of 2.82% and 4.74%.

Gross Margin	54.33%
Operating Margin	2.82%
Pretax Margin	4.64%
Profit Margin	4.74%
EBITDA Margin	12.96%
EBIT Margin	2.82%
FCF Margin	n/a

Dividends & Yields

EPA:ALGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.63%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:ALGEN has an Altman Z-Score of 2.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	4